. Author manuscript; available in PMC: 2023 Sep 1.

Published in final edited form as: Dig Liver Dis. 2022 Apr 8;54(9):1179–1185. doi: 10.1016/j.dld.2022.03.006

Table 3:

Outcomes among symptom responders and non-responders on final endoscopy

	Symptom Non-responders (n = 18)	Symptom Responders (n = 32)	p
Peak eosinophil counts (mean eos/hpf ± SD)	54.2 ± 36.8	4.1 ± 6.5	< 0.001
Histologic response < 15 eos/hpf (n, %)	0 (0)	30 (94)	< 0.001

Required dilation at final EGD (n, %)	11 (61)	12 (38)	0.11
Stricture present at final EGD (n, %)	13 (72)	10 (31)	0.005
Narrowing present at final EGD (n, %)	2 (11)	1 (3)	0.25
Esophageal diameter at final EGD (mean mm ± SD)	15.4 ± 2.8	16.4 ± 1.4	0.37

Final PPI dose (mean daily mg ± SD)	38.3 ± 18.9	40.9 ± 19.7	0.65